Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Joseph Fitzgerald currently holds 17,578 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Joseph Fitzgerald has been a net seller of ALNY stock. They have purchased $0 and sold $13.5M worth of shares.
Kevin Joseph Fitzgerald's most recent insider trade was on Apr 7, 2026, when they sold 17,578 shares at $2.56 per share.
Kevin Joseph Fitzgerald serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 63 insider transactions totaling $13.5M over their tenure at the company.
Kevin Joseph Fitzgerald holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Kevin Joseph Fitzgerald has shown a selling trading pattern, with $0 in total purchases and $13.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Joseph Fitzgerald was on Nov 17, 2025, when they sold $3.7M worth of ALNY shares. This transaction involved 8,168 shares at $449.00 per share.
Kevin Joseph Fitzgerald currently owns 17,578 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Joseph Fitzgerald's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Joseph Fitzgerald has 63 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Kevin Joseph Fitzgerald and 40,000+ other insiders.